Amarin Corp Plc (AMRN)

[Crikker]

CBB

There are lots of different models to value stocks. One using only present sales when there is such a high expected growth rate would be inappropriate.

IMO the reason why a buyout won’t happen anytime soon is that a big pharma would have to pay such a high premium to satisfy the holders of AMRN shares that they would have trouble getting approval from their own shareholders. Look at BMY and the kickback they are getting about buying CELG with a much more modest premium than AMRN would demand.

I think we should enjoy the ride during the exponential growth that appears to be right in front of us and then sell the company for a smaller premium (% not necessarily $) but a much higher price, hopefully well into triple digits.